CAS: 2007885-39-2
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
PAT-1251 REF: 3D-HFD88539CAS: 2007885-39-2 | Min. 95% | A consultar | Mar 14 Ene 25 | |
PAT-1251 REF: TM-T12371LCAS: 2007885-39-2 | 99.49% - 99.78% | 113,00 €~3.709,00 € | Mar 21 Ene 25 |
PAT-1251
CAS:2007885-39-2
PAT-1251 is a lysine-based anti-cancer drug that has been shown to be safe and effective …
Fórmula:
C18H17F4N3O3
Pureza:
Min. 95%
Peso molecular:
399.3 g/mol
Ref: 3D-HFD88539
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
PAT-1251
CAS:2007885-39-2
PAT-1251 is an inhibitor of LOXL2 with IC50s of 10, 0.12, and 0.16 μM for …
Fórmula:
C18H17F4N3O3
Pureza:
99.49% - 99.78%
Forma y color:
Solid
Peso molecular:
399.34
Ref: TM-T12371L
1mg | 113,00 € | ||
5mg | 276,00 € | ||
10mg | 400,00 € | ||
25mg | 627,00 € | ||
50mg | 843,00 € | ||
100mg | 1.090,00 € | ||
200mg | 1.460,00 € | ||
1mL*10mM (DMSO) | 303,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025